IFNA1 and melanoma: Yet, tumor-associated pDCs (TA-pDCs) generally present a dysfunctional immature phenotype, with decreased secretion of IFN-α and inability to induce appropriate T cell responses and were described as negative prognostic markers in oral, ovarian, melanoma breast cancers and others human malignancies (74–78).